reports
SeaSpine Announces 100th Placement of 7D FLASH™ Navigation System
SeaSpine Announces 100th Placement of 7D FLASH™ Navigation System CARLSBAD, Calif., Dec. 27, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the placement of its 100th 7D FLASH™ Navigation System globally. The 7D FLASH™ Navigation System uses visible light to create a three-dimensional image for surgical navigation in just seconds, which is expected to result in shorter and more efficient spinal procedures with less radiation exposure. It is the o...
Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Com...
Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing LEWISVILLE, Texas and CARLSBAD, Calif., Nov. 18, 2022 (GLOBE NEWSWIRE) -- Orthofix (NASDAQ: OFIX), a global medical device company with a spine and orthopedics focus, and SeaSpine (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that John Bostjancic will serve as Chief Financial Officer (CFO) for the new combined company, effective upon the completion of their pending merger. Bostjancic currently serves as...
SeaSpine to Present at the Stifel 2022 Healthcare Conference
SeaSpine to Present at the Stifel 2022 Healthcare Conference CARLSBAD, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company will present at the upcoming Stifel 2022 Healthcare Conference. Members of management are scheduled to present on Wednesday, November 16, 2022 at 12:35 p.m. Pacific time / 3:35 p.m. Eastern time. Interested parties can access a live webcast of the presentation directly by following this . An arch...
SeaSpine Announces 45% Revenue Growth and Record Revenue for Third Qua...
SeaSpine Announces 45% Revenue Growth and Record Revenue for Third Quarter 2022 CARLSBAD, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the third quarter of 2022. Summary Third Quarter 2022 Financial Results and Recent Highlights Total revenue of $67.1 million, an increase of 45% year-over-yearU.S. revenue of $51.1 million, an increase of 24% year-over-yearU.S. spinal implants and enabling technologies re...
SeaSpine Announces Full Commercial Launch of the Mariner MIS Wayfinder...
SeaSpine Announces Full Commercial Launch of the Mariner MIS Wayfinder System CARLSBAD, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Mariner® MIS Wayfinder System. Mariner MIS Wayfinder is a novel, one step, k-wireless screw delivery system for pedicle screw fixation. Mariner MIS Wayfinder eliminates reliance on traditional guidewires for percutaneous screw placement by providing a ful...
SeaSpine to Report Third Quarter 2022 Financial Results on November 1,...
SeaSpine to Report Third Quarter 2022 Financial Results on November 1, 2022 CARLSBAD, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release third quarter financial results after the close of trading on Tuesday, November 1, 2022. Members of the Company’s management team will host a corresponding conference call and webcast beginning at 1:30 pm PT / 4:30 pm ET. To listen to the live webcast and a replay, please visit...
SeaSpine Announces Full Commercial Launch of the 7D FLASH™ Navigation ...
SeaSpine Announces Full Commercial Launch of the 7D FLASH™ Navigation System Percutaneous Spine Module for Minimally Invasive Surgery CARLSBAD, Calif., Oct. 18, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the 7D FLASH™ Navigation System Percutaneous Spine Module. The release of the Percutaneous Module represents a new application and increased functionality for its 7D FLASH Navigation System, which now allows SeaS...
SeaSpine Announces 44% to 45% Preliminary Revenue Growth for Third Qua...
SeaSpine Announces 44% to 45% Preliminary Revenue Growth for Third Quarter 2022 and Raises Full Year 2022 Revenue Guidance CARLSBAD, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the third quarter of 2022. Preliminary and Unaudited Third Quarter 2022 Financial Results Total revenue is expected to range from $66.7 to $67.2 million, reflecting 44% to 45% year-over-year growthU.S. revenue is exp...
Orthofix and SeaSpine to Combine in Merger of Equals to Create Leading...
Orthofix and SeaSpine to Combine in Merger of Equals to Create Leading Global Spine and Orthopedics Company Highly complementary spine and orthopedics portfoliosOne of the industry’s broadest biologics and regenerative technology offeringsDifferentiated and synergistic enabling technologiesMeaningful cross-selling revenue synergies and cost savingsFinancial strength to pursue growth investments without need for immediate equity financing Expected to be adjusted EBITDA accretive to Orthofix by the second year following close including cost savings Companies to host joint conference call and ...
SeaSpine to Present at the 2022 Ladenburg Thalmann Healthcare Conferen...
SeaSpine to Present at the 2022 Ladenburg Thalmann Healthcare Conference CARLSBAD, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the company will present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29, 2022 beginning at 12:00 p.m. ET. A live and archived webcast of the event will be available from the Investors section of the SeaSpine website at: . About SeaSpine SeaSpine () is a global medical technolog...
SeaSpine Announces Full Commercial Launch of the WaveForm® TA (TLIF Ar...
SeaSpine Announces Full Commercial Launch of the WaveForm® TA (TLIF Articulating) Interbody System CARLSBAD, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the WaveForm TA (TLIF Articulating) Interbody System. The WaveForm TA Interbody System is designed to deliver an interbody to the anterior portion of the disc space to optimize sagittal alignment and endplate support. With an array of footprint ...
SeaSpine to Present at the Inaugural Gilmartin Group Emerging Growth C...
SeaSpine to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase CARLSBAD, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022 at 9:30 a.m. Pacific time / 12:30 p.m. Eastern time. Interested parties can access a li...
SeaSpine Reports 19% Revenue Growth and Record Quarterly Revenue for S...
SeaSpine Reports 19% Revenue Growth and Record Quarterly Revenue for Second Quarter 2022 and Raises Full Year 2022 Revenue Guidance CARLSBAD, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today second quarter financial results for the three-months ended June 30, 2022. Summary Second Quarter 2022 Financial Results and Recent Highlights Total revenue of $56.3 million, an increase of 19% year-over-yearU.S. revenue of $49.5 million, an...
SeaSpine® Announces Full Commercial Launch of Meridian™ Anterior Lumba...
SeaSpine® Announces Full Commercial Launch of Meridian™ Anterior Lumbar Interbody System Featuring Reef ™ A Interbody CARLSBAD, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Meridian Anterior Lumbar Interbody System featuring the Reef A interbody. This innovative, new ALIF (anterior lumbar interbody fusion) system addresses an approximately $200 million dollar market segment in the U.S. The Mer...
SeaSpine to Present at the Canaccord Genuity 42nd Annual Global Growth...
SeaSpine to Present at the Canaccord Genuity 42nd Annual Global Growth Conference CARLSBAD, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company will present at the Canaccord Genuity 42nd Annual Global Growth Conference on August 10, 2022 beginning at 8:00 AM ET. A live and archived webcast of the event will be available from the Investors section of the SeaSpine website at: . About SeaSpine SeaSpine () is a g...
- Jonathan Moreland
DAL DELTA AIR LINES INC.
SUP SUPERIOR INDUSTRIES INTERNATIONAL INC.
SPNE SEASPINE HOLDINGS CORP.
SEAC SEACHANGE INTERNATIONAL INC.
RWLK REWALK ROBOTICS LTD
QTNT QUOTIENT LTD
NDLS NOODLES & COMPANY
MIXT MIX TELEMATICS ADR
ENZ ENZO BIOCHEM INC.
CMTL COMTECH TELECOMMUNICATIONS CORP.
CARA CARA THERAPEUTICS INC
CAMP CALAMP CORP.
MEDP MEDPACE HOLDINGS INC.
HRTG HERITAGE INSURANCE HOLDINGS INC.
BBBY BED BATH & BEYOND INC.
ET ENERGY TRANSFER L.P.
IONS IONIS PHARMACEUTICALS INC.
LMT LOCKHEED MARTIN CORPORATION
THO THOR INDUSTRIES INC.
SBOW SILVERBOW RESOURCES
NEE NEXTERA ENERGY
CLIR INC.
SFIX CLEARSIGN TECHNOLOGIES CORP
TCDA STITCH FIX CLASS A
VRCA TRICIDA
ALLO VERRICA PHARMACEUTICALS
CBNK ALLOGENE THERAPEUTICS
GOSS CAPITAL BANCORP
PBYI GOSSAMER BIO
ETNB INNOVATIVE ACQUISITIONS CORP
TCON 89BIO
NREF TRACON PHARMACEUTICALS
VOXX NEXPOINT REAL ESTATE FINANCE
HPK INC.
RLAY AUDIOVOX CORPORATION
ABNB HIGHPEAK ENERGY INC (A)
POSH RELAY THERAPEUTICS
BOLT AIRBNB INC. CLASS A
LDI POSHMARK
AMWL BOLT BIOTHERAPEUTICS
LFST LOANDEPOT
BYRN AMERICAN WELL
EPIX LIFESTANCE HEALTH GROUP
COUR INC.
MCW BYRNA TECHNOLOGIES INC
TTNP EPIX PHARMACEUTICALS
SONM COURSERA INC
ANNX MISTER CAR WASH INC
TITAN PHARMACEUTICALS INC
SONIM TECHNOLOGIES INC
ANNEXIN PHARMACEUTICALS AB
SeaSpine to Report Second Quarter 2022 Financial Results on August 2, ...
SeaSpine to Report Second Quarter 2022 Financial Results on August 2, 2022 CARLSBAD, Calif., July 20, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release second quarter financial results after the close of trading on Tuesday, August 2, 2022. Members of the Company’s management team will host a corresponding conference call and webcast beginning at 1:30 pm PT / 4:30 pm ET. Individuals interested in listening to the conference call...
SeaSpine Announces Three-Year Extension and Expansion of $30 Million C...
SeaSpine Announces Three-Year Extension and Expansion of $30 Million Credit Facility Provides for up to an additional $10 million of liquidity CARLSBAD, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it has amended its credit facility with Wells Fargo Bank, N.A. The amendment extends the maturity date of the credit facility by three years from July 27, 2022 to July 27, 2025. Additionally, at any time through July 27, 2025,...
- Jonathan Moreland
DAL DELTA AIR LINES INC.
SPNE SEASPINE HOLDINGS CORP.
RMAX RE/MAX HOLDINGS INC.
QTNT QUOTIENT LTD
PFSW PFSWEB INC
NDLS NOODLES & COMPANY
IVC INVACARE CORPORATION
ENZ ENZO BIOCHEM INC.
CHK CHESAPEAKE ENERGY CORPORATION
CAMP CALAMP CORP.
AAIC ARLINGTON ASSET INVESTMENT CORP. CLASS A
HRTG HERITAGE INSURANCE HOLDINGS INC.
BBBY BED BATH & BEYOND INC.
DRI DARDEN RESTAURANTS INC.
IONS IONIS PHARMACEUTICALS INC.
MAC MACERICH COMPANY
THO THOR INDUSTRIES INC.
TIPT TIPTREE INC
ACNB ACNB CORP.
BWFG BANKWELL FINANCIAL GROUP
ARKR ARK RESTAURANTS CORP.
SBOW SILVERBOW RESOURCES
NEE NEXTERA ENERGY
CLIR INC.
SFIX CLEARSIGN TECHNOLOGIES CORP
TCDA STITCH FIX CLASS A
SFBC TRICIDA
GIM SOUND FINANCIAL BANCORP INC
VRCA TEMPLETON GLOBAL INCOME FUND
FUND VERRICA PHARMACEUTICALS
ANIX ROYCE FOCUS TRUST
GOSS INC.
ETNB ANIXA BIOSCIENCES
TCON GOSSAMER BIO
GLXZ 89BIO
ALTG TRACON PHARMACEUTICALS
NREF GALAXY GAMING INC
VOXX ALTA EQUIPMENT GROUP INC.
HPK NEXPOINT REAL ESTATE FINANCE
ATHA INC.
BOLT AUDIOVOX CORPORATION
LDI HIGHPEAK ENERGY INC (A)
VINC ATHIRA PHARMA
OBTX BOLT BIOTHERAPEUTICS
BYRN LOANDEPOT
RSVR VINCERX INC
EFTR EVERYTHING BLOCKCHAIN
TTNP INC.
SONM BYRNA TECHNOLOGIES INC
ANNX RESERVOIR MEDIA
INC.
EFFECTOR THERAPEUTICS INC
TITAN PHARMACEUTICALS INC
SONIM TECHNOLOGIES INC
ANNEXIN PHARMACEUTICALS AB
- Jonathan Moreland
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.